Shares of Apellis Pharmaceuticals Inc. (APLS), which touched a new high of $29.34 on Wednesday, are up nearly 26% year-to-date while the iShares NASDAQ Biotechnology Index (ETF)(IBB) is down 1.3% for the same period.
from RTT - Biotech https://ift.tt/2v9WTOU
via IFTTT
No comments:
Post a Comment